In our study we observed higher loss of H3K27me3 in AML than in ALL, and that was prognostic in the presence of a methylation regulating mutation (i.e. DNMT3A, IDH1-2 and/or TET2), but not without. This evidence concerns the gene IDH1 and acute lymphoblastic leukemia.